The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients

por Hochhaus, Andreas, Kantarjian, Hagop
Publicado 2013

Survival with chronic myeloid leukaemia after failing milestones

por Lauseker, Michael, Hehlmann, Rüdiger, Hochhaus, Andreas, Saußele, Susanne
Publicado 2023

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

por Hinze, Anna, Rinke, Jenny, Hochhaus, Andreas, Ernst, Thomas
Publicado 2020

Clinical, social, and psycho-oncological needs of adolescents and young adults (AYA) versus older patients following hematopoietic stem cell transplantation

por Pulewka, Kristin, Strauss, Bernhard, Hochhaus, Andreas, Hilgendorf, Inken
Publicado 2020

Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

por Fleischmann, Maximilian, Schnetzke, Ulf, Hochhaus, Andreas, Scholl, Sebastian
Publicado 2021

P683: TRIALS IN PROGRESS: FIRST-IN-HUMAN STUDY OF ELVN-001, A SELECTIVE BCR::ABL1 TYROSINE KINASE INHIBITOR, IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WHO FAILED PREVIOUS TYROSINE...

por Lang, Fabian, Branford, Susan, P. Lyssikatos, Joseph, Collins, Helen, Hochhaus, Andreas
Publicado 2023

Prof. Michele Baccarani. August 16, 1942 to December 20, 2021: a gifted life in haematology

por Saglio, Giuseppe, Rosti, Gianantonio, Hehlmann, Rüdiger, Hochhaus, Andreas, Gale, Robert Peter
Publicado 2022

Genomic Instability in Context of the Chromosomal Theory

por Fabarius, Alice, Duesberg, Peter, Giehl, Michelle, Seifarth, Wolfgang, Hochhaus, Andreas, Hehlmann, Rüdiger
Publicado 2008

EZH2 in Myeloid Malignancies

por Rinke, Jenny, Chase, Andrew, Cross, Nicholas C. P., Hochhaus, Andreas, Ernst, Thomas
Publicado 2020

The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm

por O’Hagan Henderson, Samantha, Glaser, Anita, Frietsch, Jochen J., Hochhaus, Andreas, Hilgendorf, Inken
Publicado 2021

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)

por Hehlmann, Rüdiger, Lauseker, Michael, Voskanyan, Astghik, Fabarius, Alice, Haferlach, Claudia, Hochhaus, Andreas, Saußele, Susanne
Publicado 2022

Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution

por Chen, Yulin, Möbius, Susanne, Riege, Konstantin, Hoffmann, Steve, Hochhaus, Andreas, Ernst, Thomas, Rudolph, Karl Lenhard
Publicado 2023

Psychosocial distress in young adults surviving hematological malignancies: a pilot study

por Wittwer, Andreas, Sponholz, Kristin, Frietsch, Jochen J., Linke, Paul, Kropp, Peter, Hochhaus, Andreas, Hilgendorf, Inken
Publicado 2022

P474: FUNCTIONAL (PHOSPHO-)PROTEOMICS OF DRUG RESPONSE IN ACUTE MYELOID LEUKEMIA

por Oliinyk, Denys, Fleischmann, Maximilian, Ernafasova, Dilfuza, Tschernjawski, Caroline, Scholl, Sebastian, Hochhaus, Andreas, Meier-Rosar, Florian
Publicado 2023

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure–response analysis of a Phase III study

por Wang, Xiaoning, Roy, Amit, Hochhaus, Andreas, Kantarjian, Hagop M, Chen, Tai-Tsang, Shah, Neil P
Publicado 2013

Case report: false positive elevated serum‐galactomannan levels after autologous hematopoietic stem cell transplantation caused by oral nutritional supplements

por Rachow, Tobias, Dornaus, Sebastian, Sayer, Herbert G., Hermann, Beate, Hochhaus, Andreas, von Lilienfeld‐Toal, Marie
Publicado 2016

Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors

por Hochhaus, Andreas, Breccia, Massimo, Saglio, Giuseppe, García-Gutiérrez, Valentín, Réa, Delphine, Janssen, Jeroen, Apperley, Jane
Publicado 2020

PB1972: ASC4START: A PHASE IIIB, OPEN-LABEL, RANDOMIZED STUDY OF ASCIMINIB VERSUS NILOTINIB IN PATIENTS WITH NEWLY DIAGNOSED PH+ CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

por Hochhaus, Andreas, Saussele, Susanne, Mahon, Francois-Xavier, Pilipovic, Virginia, Zhang, Yifan, Schuld, Peter, Brümmendorf, Tim H
Publicado 2023

PB1774: PHARMACOLOGICAL STRATEGIES TO OVERCOME RESISTANCE IN AML CELL LINE MODELS HARBORING ACTIVATING FLT3-ITD AND PTPN11 MUTATIONS

por Fleischmann, Maximilian, Urban, Nathalie, Hansen, Ole, Schnetzke, Ulf, Heidel, Florian, Hochhaus, Andreas, Mueller, Joerg, Scholl, Sebastian
Publicado 2023

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

por O‘Hagan Henderson, Samantha, Frietsch, Jochen J., Hilgendorf, Inken, Hochhaus, Andreas, Köhne, Claus-Henning, Casper, Jochen
Publicado 2021